Is one spray of azelastine nasal spray in each nostril once daily appropriate for children up to 11 years of age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Azelastine Dosing for Children Up to Age 11

No, one spray in each nostril is NOT correct for all children up to age 11—the FDA-approved dosing for azelastine nasal spray varies by age, with children ages 5-11 years receiving 1 spray per nostril twice daily for seasonal allergic rhinitis, while children under 5 years have no established dosing as azelastine is not FDA-approved for this age group. 1

FDA-Approved Dosing by Age Group

Children Ages 5-11 Years

  • For seasonal allergic rhinitis: 1 spray per nostril twice daily 1
  • This lower dose (compared to adults) has been specifically studied and demonstrates efficacy with improved tolerability 2

Children Ages 12 Years and Older

  • For seasonal allergic rhinitis: 1 or 2 sprays per nostril twice daily 1
  • For vasomotor rhinitis: 2 sprays per nostril twice daily 1

Children Under 5 Years

  • Azelastine nasal spray is not FDA-approved for children under 5 years of age 1
  • No safety or efficacy data exist for this age group

Clinical Evidence Supporting Age-Specific Dosing

The 1-spray-per-nostril twice-daily regimen for younger children (ages 5-11) is supported by clinical trial data showing:

  • Significant efficacy: Mean differences in total nasal symptom scores between azelastine 1 spray per nostril twice daily and placebo were statistically significant (P = .01 and P = .02 in two separate studies) 2
  • Improved tolerability: Bitter taste occurred in only 8.3% of patients using 1 spray per nostril twice daily compared to 19.7% with the standard 2-spray regimen 2
  • Reduced sedation: Somnolence was reported by only 0.4% using the 1-spray regimen compared to 11.5% with the 2-spray regimen 2

Proper Administration Technique

Regardless of age, proper technique is essential for efficacy and safety:

  • Keep head tilted downward toward toes when spraying (not tilted back) 1
  • Alternate sprays between nostrils 1
  • Breathe gently to avoid drawing medication into the throat 1
  • Prime the pump with 4 sprays or less before initial use 1
  • If 3 or more days have elapsed since last use, reprime with 2 sprays 1

Common Pitfalls to Avoid

Age-related errors: Do not use the adult 2-spray-per-nostril regimen in children ages 5-11 years, as this doubles the intended dose and increases side effects without additional benefit 1, 2

Improper head position: Tilting the head backward after dosing draws medication into the throat, causing bitter taste and reducing nasal delivery 1

Confusion with other antihistamines: Unlike oral second-generation antihistamines, azelastine nasal spray has age-specific dosing that must be followed 3, 1

Safety Profile in Pediatric Patients

The lower dose for children ages 5-11 years maintains efficacy while minimizing the most common adverse effects:

  • Bitter taste is the most frequent complaint but occurs less often with the 1-spray regimen 1, 2
  • Somnolence is rare (0.4%) with the pediatric dose 2
  • Nasal burning or stinging may occur briefly after administration 1

In case of accidental ingestion by a young child, seek professional assistance or contact a poison control center immediately 1

References

Research

Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.